About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sepraspray™ Laparoscopic Myomectomy Study

NCT00624390·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Genzyme, a Sanofi Company

Age

18–50

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

The patient must be a premenopausal women with myomas associated with clinical symptoms deemed suitable for laparoscopic myomectomy and SLL.

You may not be if

Pregnant/lactating women.
The patient has a history of hypersensitivity to exogenous carboxymethylcellulose products and/or hyaluronic acid.
The patient's procedure resulted in entry of the endometrial cavity, or entry of the bowel including appendectomy.

The record

StatusCompleted

PhaseNo phase

Taking part41

StartedNov 2007

UpdatedDec 14, 2016

Conditions

Laparoscopic Myomectomy

Where3

Naperville, Illinois, United States
Philadelphia, Pennsylvania, United States
Austin, Texas, United States

Clareo Health | Sepraspray™ Laparoscopic Myomectomy Study